STAAR Surgical Company (STAA)
NASDAQ: STAA · Real-Time Price · USD
16.10
-0.39 (-2.37%)
Feb 13, 2026, 4:00 PM EST - Market closed
STAAR Surgical Company Stock Forecast
Stock Price Forecast
The 10 analysts that cover STAAR Surgical Company stock have a consensus rating of "Hold" and an average price target of $22.63, which forecasts a 40.56% increase in the stock price over the next year. The lowest target is $16 and the highest is $30.75.
Price Target: $22.63 (+40.56%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for STAAR Surgical Company stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 8 | 8 | 8 | 10 | 10 | 11 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 10 | 11 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Hold Maintains $28 → $19 | Hold | Maintains | $28 → $19 | +18.01% | Feb 9, 2026 |
| Wedbush | Wedbush | Hold Initiates $26 | Hold | Initiates | $26 | +61.49% | Feb 3, 2026 |
| Jefferies | Jefferies | Strong Buy Maintains $28 → $22 | Strong Buy | Maintains | $28 → $22 | +33.54% | Jan 28, 2026 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $31 → $22 | Hold | Maintains | $31 → $22 | +36.65% | Jan 16, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $28 → $31 | Hold | Maintains | $28 → $31 | +90.99% | Dec 10, 2025 |
Financial Forecast
Revenue This Year
262.72M
from 313.90M
Decreased by -16.30%
Revenue Next Year
319.98M
from 262.72M
Increased by 21.80%
EPS This Year
-1.11
from -0.41
EPS Next Year
0.06
from -1.11
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 272.9M | 361.7M | ||||
| Avg | 262.7M | 320.0M | ||||
| Low | 249.5M | 275.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -13.1% | 37.7% | ||||
| Avg | -16.3% | 21.8% | ||||
| Low | -20.5% | 4.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.54 | 0.40 | |||
| Avg | -1.11 | 0.06 | |||
| Low | -1.31 | -0.31 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.